Bioxcel Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $627k | 222k | 2.82 |
| 2023-09-30 | $514k | 203k | 2.53 |
| 2023-06-30 | $619k | 93k | 6.66 |
| 2022-12-31 | $2.7M | 125k | 21.48 |
| 2022-06-30 | $3.0M | 227k | 13.19 |
| 2022-03-31 | $4.4M | 211k | 20.91 |
| 2021-06-30 | $0 | 119k | 0.00 |
| 2020-12-31 | $1.0M | 22k | 46.16 |
| 2020-09-30 | $777k | 18k | 43.36 |
| 2020-06-30 | $387k | 7.3k | 52.94 |
| 2020-03-31 | $100k | 4.5k | 22.35 |
| 2019-12-31 | $150k | 10k | 14.66 |
| 2019-09-30 | $20k | 2.7k | 7.19 |
| 2019-03-31 | $24k | 2.5k | 9.59 |
| 2018-12-31 | $0 | 4.1k | 0.00 |
| 2018-09-30 | $73k | 5.2k | 13.89 |
| 2018-06-30 | $11k | 1.2k | 8.89 |
| 2018-03-31 | $30k | 2.9k | 10.33 |